Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Judge

Showing results (241-250 of 260) with videos related to

Pageof 26
Sort By:
JAMA Cardiology|November 8, 2025
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label ExtensionKevin M Alexander, Margot K Davis, Olakunle Akinboboye, et al.
Genome Medicine|October 23, 2023
Beyond gene-disease validity: capturing structured data on inheritance, allelic requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditionsKatherine S Josephs, Angharad M Roberts, Pantazis Theotokis, et al.
Heart Rhythm|May 13, 2019
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathyJeffrey A Towbin, William J McKenna, Dominic J Abrams, et al.
Circulation. Cardiovascular Genetics|March 31, 2015
Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family MembersJudith A Groeneweg, Aditya Bhonsale, Cynthia A James, et al.
Heart Rhythm|November 3, 2019
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summaryJeffrey A Towbin, William J McKenna, Dominic J Abrams, et al.
Circulation|March 20, 2023
Effectiveness of the <i>Family Heart Talk</i> Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized TrialDaniel D Kinnamon, Elizabeth Jordan, Garrie J Haas, et al.
JAMA|February 1, 2022
Prevalence and Cumulative Risk of Familial Idiopathic Dilated CardiomyopathyGordon S Huggins, Daniel D Kinnamon, Garrie J Haas, et al.
Circulation|September 30, 2021
Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating VariantsMarta Gigli, Davide Stolfo, Sharon L Graw, et al.
Cardiovascular Research|January 11, 2017
Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesisAnneline S J M Te Riele, Esperanza Agullo-Pascual, Cynthia A James, et al.
JAMA|August 1, 2023
Genetic Architecture of Dilated Cardiomyopathy in Individuals of African and European AncestryElizabeth Jordan, Daniel D Kinnamon, Garrie J Haas, et al.
Pageof 26

Showing results (241-250 of 260) with videos related to

Sort By:
Pageof 26
JAMA Cardiology|November 8, 2025
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label ExtensionKevin M Alexander, Margot K Davis, Olakunle Akinboboye, et al.
Genome Medicine|October 23, 2023
Beyond gene-disease validity: capturing structured data on inheritance, allelic requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditionsKatherine S Josephs, Angharad M Roberts, Pantazis Theotokis, et al.
Heart Rhythm|May 13, 2019
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathyJeffrey A Towbin, William J McKenna, Dominic J Abrams, et al.
Circulation. Cardiovascular Genetics|March 31, 2015
Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family MembersJudith A Groeneweg, Aditya Bhonsale, Cynthia A James, et al.
Heart Rhythm|November 3, 2019
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summaryJeffrey A Towbin, William J McKenna, Dominic J Abrams, et al.
Circulation|March 20, 2023
Effectiveness of the <i>Family Heart Talk</i> Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized TrialDaniel D Kinnamon, Elizabeth Jordan, Garrie J Haas, et al.
JAMA|February 1, 2022
Prevalence and Cumulative Risk of Familial Idiopathic Dilated CardiomyopathyGordon S Huggins, Daniel D Kinnamon, Garrie J Haas, et al.
Circulation|September 30, 2021
Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating VariantsMarta Gigli, Davide Stolfo, Sharon L Graw, et al.
Cardiovascular Research|January 11, 2017
Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesisAnneline S J M Te Riele, Esperanza Agullo-Pascual, Cynthia A James, et al.
JAMA|August 1, 2023
Genetic Architecture of Dilated Cardiomyopathy in Individuals of African and European AncestryElizabeth Jordan, Daniel D Kinnamon, Garrie J Haas, et al.
Pageof 26